These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27847895)

  • 1. Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease.
    Tian PW; Wen FQ
    J Transl Int Med; 2015; 3(3):89-92. PubMed ID: 27847895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical issues of mucus accumulation in COPD.
    Ramos FL; Krahnke JS; Kim V
    Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.
    Ohar JA; Donohue JF; Spangenthal S
    Chronic Obstr Pulm Dis; 2019 Oct; 6(4):341-9. PubMed ID: 31647856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucus hypersecretion in chronic obstructive pulmonary disease.
    Rogers DF
    Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic bronchitis and chronic obstructive pulmonary disease.
    Kim V; Criner GJ
    Am J Respir Crit Care Med; 2013 Feb; 187(3):228-37. PubMed ID: 23204254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role and Regulatory Mechanisms of MUC5AC in Chronic Obstructive Pulmonary Disease.
    Li J; Ye Z
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32992527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
    Tesfaigzi Y; Meek P; Lareau S
    Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
    Rogers DF
    COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review).
    Zhang T; Zhou X
    Exp Ther Med; 2014 Apr; 7(4):763-767. PubMed ID: 24660026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment.
    Shah BK; Singh B; Wang Y; Xie S; Wang C
    Mediators Inflamm; 2023; 2023():8840594. PubMed ID: 37457746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoactive drugs and multiple applications in pulmonary disease therapy.
    Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
    Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].
    Wang S; Xiong L; Deng X; Ren W; Zhu C; Li C; Zhou Q
    Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(22):1726-30. PubMed ID: 26704155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).
    Shen Y; Huang S; Kang J; Lin J; Lai K; Sun Y; Xiao W; Yang L; Yao W; Cai S; Huang K; Wen F
    Int J Chron Obstruct Pulmon Dis; 2018; 13():399-407. PubMed ID: 29430174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisited role for mucus hypersecretion in the pathogenesis of COPD.
    Cerveri I; Brusasco V
    Eur Respir Rev; 2010 Jun; 19(116):109-12. PubMed ID: 20956178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 neutralizing antibody attenuates the hypersecretion of airway mucus via inducing the nuclear translocation of Nrf2 in chronic obstructive pulmonary disease.
    Wei YY; Zhang DW; Ye JJ; Lan QX; Ji S; Sun L; Li F; Fei GH
    Biomed Pharmacother; 2022 Aug; 152():113244. PubMed ID: 35687911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of coexistence of mild OSA on airway mucus hypersecretion in patients with COPD.
    Wan N; Tang X; Ding H; Yan Y; Zhuang Y; Qi C; Chen Q; Xie W; Zhang J; Wang Y; Liang M; Ning W; Cao J
    J Breath Res; 2021 Feb; 15(2):. PubMed ID: 33339013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.